Our antibody discovery platform, AbTheneum, delivers native antibody sequences paired with phenotypic data. We use the best source of immune cells to mine the immune repertoire. We have worked with several pharmaceutical companies over the last decade on numerous discovery campaigns. AbTheneum can screen antibodies upfront for epitope specificity, cross-reactivity, isotype, and several other customized options for your target.